Geoffrey Sklar, MD

home / authors / geoffrey-sklar-md

Articles

Dr. Sklar on Challenges With Clinical Trials in Bladder Cancer

February 7th 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses some of the challenges that come with conducting clinical trials in the treatment of patients with bladder cancer.

Dr. Sklar on Immunotherapy Potential in Bladder Cancer

Geoffrey Sklar, MD

January 28th 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the potential of immunotherapy agents in the treatment of patients with bladder cancer.

Dr. Sklar on the Role of Nivolumab in Bladder Cancer

Geoffrey Sklar, MD

January 10th 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the role of nivolumab in the treatment of patients with bladder cancer.

Dr. Geoffrey Sklar On Immunotherapy Advancements in Bladder Cancer

Geoffrey Sklar, MD

November 5th 2016

Dr. Geoffrey Sklar, Chief Medical Officer, Chesapeake Urology Associates, spoke with OncLive about some of the exciting advancements in bladder cancer during the LUGPA Annual Meeting.